SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-009666
Filing Date
2016-05-12
Accepted
2016-05-12 07:02:37
Documents
71
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 495521
2 ex31-1.htm EX-31.1 22761
3 ex31-2.htm EX-31.2 22341
4 ex32-1.htm EX-32.1 7940
5 ex32-2.htm EX-32.2 8340
  Complete submission text file 0001493152-16-009666.txt   3286549

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aker-20160331.xml EX-101.INS 526889
7 XBRL SCHEMA FILE aker-20160331.xsd EX-101.SCH 47315
8 XBRL CALCULATION FILE aker-20160331_cal.xml EX-101.CAL 54475
9 XBRL DEFINITION FILE aker-20160331_def.xml EX-101.DEF 128488
10 XBRL LABEL FILE aker-20160331_lab.xml EX-101.LAB 337268
11 XBRL PRESENTATION FILE aker-20160331_pre.xml EX-101.PRE 226599
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences Inc (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 161641625
SIC: 2835 In Vitro & In Vivo Diagnostic Substances